These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25398389)

  • 21. Emerging Entities in Renal Neoplasia.
    Mehra R; Smith SC; Divatia M; Amin MB
    Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
    Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
    Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma.
    Zhang BY; Cheville JC; Thompson RH; Lohse CM; Boorjian SA; Leibovich BC; Costello BA
    Eur Urol; 2015 Jul; 68(1):5-7. PubMed ID: 25638439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
    Williamson SR; Gill AJ; Argani P; Chen YB; Egevad L; Kristiansen G; Grignon DJ; Hes O
    Am J Surg Pathol; 2020 Jul; 44(7):e47-e65. PubMed ID: 32251007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
    Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
    Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
    Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gleason and Fuhrman no longer make the grade.
    Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
    Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.
    Moch H; Gasser T; Amin MB; Torhorst J; Sauter G; Mihatsch MJ
    Cancer; 2000 Aug; 89(3):604-14. PubMed ID: 10931460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
    Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidentally detected clear cell renal cell carcinoma with rhabdoid differentiation.
    Krishnamoorthy V; Gowda KK; Rao RN
    Indian J Pathol Microbiol; 2016; 59(4):507-509. PubMed ID: 27721283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects.
    Kuroda N; Karashima T; Inoue K; Kasajima A; Ohe C; Kawakami F; Mikami S; Matsuura K; Moriyama M; Nagashima Y; Petersson F; Lopez JI; Cohen RJ; Michal M; Hes O
    Pol J Pathol; 2015 Mar; 66(1):3-8. PubMed ID: 26017874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiT family translocation renal cell carcinoma.
    Argani P
    Semin Diagn Pathol; 2015 Mar; 32(2):103-13. PubMed ID: 25758327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
    Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations.
    Trpkov K; Grignon DJ; Bonsib SM; Amin MB; Billis A; Lopez-Beltran A; Samaratunga H; Tamboli P; Delahunt B; Egevad L; Montironi R; Srigley JR;
    Am J Surg Pathol; 2013 Oct; 37(10):1505-17. PubMed ID: 24025521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances and controversies in grading and staging of renal cell carcinoma.
    Delahunt B
    Mod Pathol; 2009 Jun; 22 Suppl 2():S24-36. PubMed ID: 19494851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary update on pathology-related issues of adult renal neoplasms.
    Mazzucchelli R; Galosi AB; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):1-8. PubMed ID: 24902365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma.
    Paner GP; Chumbalkar V; Montironi R; Moch H; Amin MB
    Adv Anat Pathol; 2022 May; 29(3):117-130. PubMed ID: 35275846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.